Klotho Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.35	0.06	0	0.08	0.3	0.33
Cash & Short-Term Investments	7.35	0.06	0	0.08	0.3	0.33
Cash Growth	14337.63%	2169.98%	-96.30%	-74.78%	-10.16%	47.29%
Receivables	0.34	-	-	0.25	-	-
Prepaid Expenses	0.09	0.09	0	0	0	-
Total Current Assets	7.77	0.16	0.01	0.33	0.3	0.33
Other Intangible Assets	2.3	2.3	2.19	2.21	0.74	0.74
Total Assets	10.07	2.46	2.19	2.54	1.04	1.07
Accounts Payable	0.03	0.06	0.15	0.01	0.02	-
Accrued Expenses	0.06	0.94	0.16	0	-	-
Short-Term Debt	-	0.24	1.31	1.35	-	-
Total Current Liabilities	0.09	1.25	1.62	1.36	0.02	-
Other Long-Term Liabilities	0.05	0.02	-	-	-	-
Total Liabilities	0.15	1.27	1.62	1.36	0.02	-
Common Stock	0.01	0	0	0.1	0.1	-
Additional Paid-In Capital	29.71	11.75	4.49	3.54	3.54	2.58
Retained Earnings	-19.79	-10.56	-3.92	-3.22	-2.62	-1.51
Comprehensive Income & Other	-	-	-	0.75	-	-
Total Common Equity	9.93	1.19	0.57	1.18	1.03	1.07
Shareholders' Equity	9.93	1.19	0.57	1.18	1.03	1.07
Total Liabilities & Equity	10.07	2.46	2.19	2.54	1.04	1.07
Total Debt	-	0.24	1.31	1.35	-	-
Net Cash (Debt)	7.35	-0.18	-1.31	-1.27	0.3	0.33
Net Cash Growth	14337.63%	-	-	-	-10.16%	404.65%
Net Cash Per Share	0.20	-0.01	-0.09	-0.00	0.00	-
Filing Date Shares Outstanding	72.54	28.51	1,045	1,045	1,045	-
Total Common Shares Outstanding	70.33	27.08	1,045	1,045	1,045	-
Working Capital	7.68	-1.09	-1.61	-1.03	0.29	0.33
Book Value Per Share	0.14	0.04	0.00	0.00	0.00	-
Tangible Book Value	7.63	-1.11	-1.61	-1.03	0.29	0.33
Tangible Book Value Per Share	0.11	-0.04	-0.00	-0.00	0.00	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q